Filter
486
Featured
47
123
Language
Document type
371
42
22
14
8
8
8
6
6
1
Countries
122
110
88
68
66
63
60
56
53
39
35
28
26
25
21
14
14
8
6
5
5
4
4
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
41
34
17
13
3
Training: Infection Prevention and Control for Marburg Virus Disease in Non-U.S. Healthcare Settings
These training materials apply to all healthcare facilities that are not designated MVD treatment facilities.
All health and care workers require the knowledge and skills to prevent the transmission of Ebola virus or Marburg virus when providing care for patients. This course provides an overview of the mode of transmission of these viruses, the personal protective equipment required by health and care work
...
This course introduces Marburg Virus Disease and outlines the signs, symptoms, diagnosis, transmission routes and epidemiology of the disease. It also discusses prevention and control strategies.
The purpose of this interim guidance is to provide recommendations for planning and implementing RCCE activities that protect and empower communities during MVD outbreaks. The guidance is designed for national and subnational health responders involved in RCCE for MVD readiness and response. It is a
...
Resource Platform
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Guidance for health care workers.
Issue Brief: Ebola
recommended
MEDBOX Issue Brief no. 24 (Sept.2022)
On 20 September 2022, Uganda health authorities declared an outbreak of Ebola disease, caused by Sudan virus,
following laboratory confirmation of a patient from a village in Madudu sub-county, Mubende district, central
Uganda.
Therefore the MEDBOX Team cre
...
Poster for communities and health worker
Fact Sheet
Hey Facts about the disease
It is believed that fruit bats are the natural hosts of the Ebola virus Introduced into the human population through close contact with infected animals. Introduction to Ebola Virus Disease (EVD) presentation is part of the EVD IPC training material for HC IIs and Pharmacies.
IPC Scorecard presentation is an EVD IPC training material to help health facilities collect information about the health facility assessment. The Scorecard is not for EVD treatment centres (separate assessment).
Putting on and Removing PPE in the context of EVD presentation is an EVD IPC training material for HC IIs and pharmacies.
Seeing a potential problem doesn’t mean the problem will definitely happen. We take action to keep something bad from happening. Risk Recognition & IPC Assessment presentation is a descriptive EVD IPC training material for health facilities and pharmacies.
Screening, Holding, Notification at a Healthcare Facility during an EVD outbreak presentation is an EVD IPC training material describing how to observe all persons entering the facility by taking non- contact temperature, and asking relevant questions. The key outcome is to determine if patient is s
...
